(Q44087009)

29 November 2017

title

Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas (English)

1 reference

29 November 2017

1 reference

Lavey RS

1

1 reference

29 November 2017

Eby NL

series ordinal

2

1 reference

29 November 2017

Prosnitz LR

series ordinal

3

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 1990

1 reference

29 November 2017

1 reference

29 November 2017

volume

66

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

80-88

1 reference

The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984.

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819900701%2966%3A1%3C80%3A%3AAID-CNCR2820660116%3E3.0.CO%3B2-9

Crossref

reference URL

Combined modality treatment for stage I-II non-Hodgkin's lymphomas: CVP versus BACOP chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819900701%2966%3A1%3C80%3A%3AAID-CNCR2820660116%3E3.0.CO%3B2-9

Crossref

reference URL

Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819900701%2966%3A1%3C80%3A%3AAID-CNCR2820660116%3E3.0.CO%3B2-9

Crossref

reference URL

10.1002/1097-0142(19900701)66:1<80::AID-CNCR2820660116>3.0.CO;2-9

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference